Nurix Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Nurix Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q3 2024.
  • Nurix Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending August 31, 2024 was 72.8M shares, a 33.8% increase year-over-year.
  • Nurix Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 54.3M shares, a 11.8% increase from 2022.
  • Nurix Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 48.6M shares, a 13.3% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 72.8M +18.4M +33.8% Jun 1, 2024 Aug 31, 2024 10-Q 2024-10-11
Q2 2024 62.4M +8.12M +15% Mar 1, 2024 May 31, 2024 10-Q 2024-07-11
Q1 2024 54.9M +875K +1.62% Dec 1, 2023 Feb 29, 2024 10-Q 2024-04-10
Q4 2023 54.3M +5.73M +11.8% Sep 1, 2023 Nov 30, 2023 10-K 2024-02-15
Q3 2023 54.4M +3.52M +6.92% Jun 1, 2023 Aug 31, 2023 10-Q 2024-10-11
Q2 2023 54.3M +9.36M +20.8% Mar 1, 2023 May 31, 2023 10-Q 2024-07-11
Q1 2023 54M +9.33M +20.9% Dec 1, 2022 Feb 28, 2023 10-Q 2024-04-10
Q4 2022 48.6M Sep 1, 2022 Nov 30, 2022 10-K 2024-02-15
Q3 2022 50.9M +6.49M +14.6% Jun 1, 2022 Aug 31, 2022 10-Q 2023-10-12
Q2 2022 44.9M +1.09M +2.5% Mar 1, 2022 May 31, 2022 10-Q 2023-07-13
Q1 2022 44.7M Dec 1, 2021 Feb 28, 2022 10-Q 2023-04-13
Q3 2021 44.4M +27.4M +162% Jun 1, 2021 Aug 31, 2021 10-Q 2022-10-06
Q2 2021 43.8M +40.1M +1074% Mar 1, 2021 May 31, 2021 10-Q 2022-07-07
Q3 2020 16.9M Jun 1, 2020 Aug 31, 2020 10-Q 2021-10-14
Q2 2020 3.73M Mar 1, 2020 May 31, 2020 10-Q 2021-07-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.